Drug: neulasta Quarter: 2016Q3
Total Drug/Injury Combinations: 516 Number of Pages: 26
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| NEULASTA | Neoplasm progression | 3 | view events |
| NEULASTA | Rash macular | 3 | view events |
| NEULASTA | Recurrent cancer | 3 | view events |
| NEULASTA | Seizure | 3 | view events |
| NEULASTA | Soft tissue swelling | 3 | view events |
| NEULASTA | Swelling face | 3 | view events |
| NEULASTA | Tachycardia | 3 | view events |
| NEULASTA | Tinnitus | 3 | view events |
| NEULASTA | Tumour pain | 3 | view events |
| NEULASTA | Accidental exposure to product | 2 | view events |
| NEULASTA | Agitation | 2 | view events |
| NEULASTA | Alanine aminotransferase increased | 2 | view events |
| NEULASTA | Anaphylactic reaction | 2 | view events |
| NEULASTA | Aplasia | 2 | view events |
| NEULASTA | Application site bruise | 2 | view events |
| NEULASTA | Application site erythema | 2 | view events |
| NEULASTA | Application site necrosis | 2 | view events |
| NEULASTA | Application site pruritus | 2 | view events |
| NEULASTA | Atrial fibrillation | 2 | view events |
| NEULASTA | Bacterial infection | 2 | view events |
Total Drug/Injury Combinations: 516 Number of Pages: 26
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)